Nakamura Hiroki, Tomuschat Christian, Coyle David, O'Donnel Anne-Marie, Lim Tristan, Puri Prem
National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland.
Department of Pediatric Surgery, Children's Hospital at Westmead, Westmead, NSW, Australia.
Pediatr Surg Int. 2018 Feb;34(2):121-128. doi: 10.1007/s00383-017-4178-0. Epub 2018 Jan 30.
Hirschsprung's disease-associated enterocolitis (HAEC) is the most serious complication of Hirschsprung's disease (HSCR). HAEC occurs in 17-50% of patients with HSCR and may occur before or after a properly performed pull-through operation. The pathogenesis of HAEC is poorly understood. It is well recognized that a complex mucosal barrier protects, as the first line of defense, the surface of healthy intestinal tract from adhesion and invasion by luminal micro-organisms. Within the intestinal epithelium, goblet cells secrete gel-forming mucins, the major component of mucus, which block the direct attachment of commensal bacteria to the epithelial layer. Mucin 2 (MUC2) is the predominant mucin expressed in humans. Trefoil factor 3 (TFF3) synergizes with mucin and enhances the protective barrier properties of the mucus layer. SAM pointed domain-containing ETS transcription factor (SPDEF) drives terminal differentiation and maturation of secretory progenitors into goblet cells. Krueppel-like factor 4 (KLF4) is a goblet cell-specific differentiation factor in the colon and controls goblet cell differentiation and activates mucin synthesis. We hypothesized that the goblet cell function in the ganglionic pulled-through bowel in HSCR is abnormal and, therefore, we investigated the changes in goblet cell differentiation and functional expression of mucin in the bowel specimens from patients with HSCR.
We investigated MUC2, TFF3, SPDEF and KLF4 expression, and the goblet cell population in the ganglionic and aganglionic bowel of HSCR patients (n = 10) and controls (n = 10) by qPCR, Western blotting, confocal immunofluorescence, and alcian blue staining.
The qPCR and Western blotting analysis revealed that TFF3, SPDEF and KLF4 expressions were significantly downregulated in the aganglionic and ganglionic colon of patients with HSCR as compared to controls (p < 0.05). Alcian blue staining revealed that the goblet cell population was significantly decreased in aganglionic and ganglionic colon as compared to controls (p < 0.05). Confocal microscopy revealed a markedly decreased expression of TFF3, SPDEF and KLF4 in colonic epithelium of patients with HSCR as compared to controls.
This is, to our knowledge, the first report of decreased expression of TFF3, SPDEF, KLF4, and goblet cell population in the colon of patients with HSCR. Altered goblet cell function may result in intestinal barrier dysfunction contributing to the development of HAEC.
先天性巨结肠相关小肠结肠炎(HAEC)是先天性巨结肠(HSCR)最严重的并发症。17% - 50%的HSCR患者会发生HAEC,且可能在正确实施拖出式手术之前或之后出现。HAEC的发病机制尚不清楚。众所周知,复杂的黏膜屏障作为第一道防线,保护健康肠道表面免受腔内微生物的黏附和侵袭。在肠道上皮内,杯状细胞分泌形成凝胶的黏蛋白,即黏液的主要成分,它可阻止共生细菌直接附着于上皮层。黏蛋白2(MUC2)是人类表达的主要黏蛋白。三叶因子3(TFF3)与黏蛋白协同作用,增强黏液层的保护屏障特性。含SAM结构域的ETS转录因子(SPDEF)驱动分泌祖细胞终末分化并成熟为杯状细胞。Krüppel样因子4(KLF4)是结肠中杯状细胞特异性分化因子,控制杯状细胞分化并激活黏蛋白合成。我们推测HSCR患者神经节拖出肠段中的杯状细胞功能异常,因此,我们研究了HSCR患者肠标本中杯状细胞分化及黏蛋白功能表达的变化。
我们通过定量聚合酶链反应(qPCR)、蛋白质免疫印迹法、共聚焦免疫荧光法和阿尔新蓝染色,研究了HSCR患者(n = 10)和对照组(n = 10)神经节段和无神经节段肠段中MUC2、TFF3、SPDEF和KLF4的表达以及杯状细胞数量。
qPCR和蛋白质免疫印迹分析显示,与对照组相比,HSCR患者无神经节段和神经节段结肠中TFF3、SPDEF和KLF4的表达显著下调(p < 0.05)。阿尔新蓝染色显示,与对照组相比,无神经节段和神经节段结肠中杯状细胞数量显著减少(p < 0.05)。共聚焦显微镜检查显示,与对照组相比,HSCR患者结肠上皮中TFF3、SPDEF和KLF4的表达明显降低。
据我们所知,这是首篇关于HSCR患者结肠中TFF3、SPDEF、KLF4表达降低及杯状细胞数量减少的报道。杯状细胞功能改变可能导致肠道屏障功能障碍,促使HAEC的发生。